Learn the applications of neoantigen peptides as personalized Cancer Vaccine (PCV), solid tumor immuno-therapy, and the solutions for neoantigen production, through GenScript’s proprietary technologies, for precision immunotherapy development.
12-07-2022 Gracie Chia, Field Application Scientist, GenScript
09-19-2022 Dr. Fengmei Pi, Head of RNA Biology Department, GenScript
The Chinese Hamster Ovary (CHO) cells is the main choice for protein expression in bioprocessing industry.
05-26-2021 Dr. Shuting Xu, FAS, EU CEC Department
With the 5th approval on CAR-T therapy (Abecma) by FDA in early 2021, ex vivo engineered T cell therapy was proved as a mainstay in cancer treatment.
05-19-2021 Dr. Lumeng Ye, Senior Scientist R&D department
Western blotting is the most commonly used technique in the lab. However, the traditional workflow is time consuming, yet difficulties persist in obtaining consistent results. GenScript has developed instrument-based one-stop solutions to accelerate prote
05-06-2021 Dr. John Yu, Project Manager Catalogue Products
Covid Passport: Vaccination vs Immunization
04-30-2021 Prof Linfa Wang